Lumacad, Fe C.

HRN: 22-34-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2022
AZITHROMYCIN 500MG TABLET (TAB)
12/18/2022
12/23/2022
PO
500 Mg
OD
CAP-MR
Waiting Final Action 
12/18/2022
CEFTRIAXONE 1G (VIAL)
12/18/2022
12/25/2022
IV
2 Grams
Q24H
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: